MXPA02006323A - Piperidiniloxi y pirrolidiniloxifenil oxazolidinonas como antibacteriales. - Google Patents

Piperidiniloxi y pirrolidiniloxifenil oxazolidinonas como antibacteriales.

Info

Publication number
MXPA02006323A
MXPA02006323A MXPA02006323A MXPA02006323A MXPA02006323A MX PA02006323 A MXPA02006323 A MX PA02006323A MX PA02006323 A MXPA02006323 A MX PA02006323A MX PA02006323 A MXPA02006323 A MX PA02006323A MX PA02006323 A MXPA02006323 A MX PA02006323A
Authority
MX
Mexico
Prior art keywords
pyrrolidinyloxyphenyl
piperidinyloxy
oxazolidinones
antibacterials
pyrrolidinyloxyphenyl oxazolidinones
Prior art date
Application number
MXPA02006323A
Other languages
English (en)
Spanish (es)
Inventor
Michele Weidnerwells
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA02006323A publication Critical patent/MXPA02006323A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MXPA02006323A 1999-12-21 2000-12-14 Piperidiniloxi y pirrolidiniloxifenil oxazolidinonas como antibacteriales. MXPA02006323A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17292399P 1999-12-21 1999-12-21
PCT/US2000/033835 WO2001046164A1 (en) 1999-12-21 2000-12-14 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials

Publications (1)

Publication Number Publication Date
MXPA02006323A true MXPA02006323A (es) 2003-09-22

Family

ID=22629768

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006323A MXPA02006323A (es) 1999-12-21 2000-12-14 Piperidiniloxi y pirrolidiniloxifenil oxazolidinonas como antibacteriales.

Country Status (17)

Country Link
US (1) US6518285B2 (cg-RX-API-DMAC7.html)
EP (1) EP1246810B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003518106A (cg-RX-API-DMAC7.html)
CN (1) CN1227238C (cg-RX-API-DMAC7.html)
AR (1) AR029420A1 (cg-RX-API-DMAC7.html)
AT (1) ATE326452T1 (cg-RX-API-DMAC7.html)
AU (1) AU784314B2 (cg-RX-API-DMAC7.html)
CA (1) CA2395204C (cg-RX-API-DMAC7.html)
CO (1) CO5280081A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106124T1 (cg-RX-API-DMAC7.html)
DE (1) DE60028085T2 (cg-RX-API-DMAC7.html)
DK (1) DK1246810T3 (cg-RX-API-DMAC7.html)
ES (1) ES2265365T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA02006323A (cg-RX-API-DMAC7.html)
MY (1) MY127677A (cg-RX-API-DMAC7.html)
PT (1) PT1246810E (cg-RX-API-DMAC7.html)
WO (1) WO2001046164A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
US6940748B2 (en) 2002-05-16 2005-09-06 Micron Technology, Inc. Stacked 1T-nMTJ MRAM structure
EP1594852A1 (en) * 2003-02-07 2005-11-16 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
MXPA05011654A (es) 2003-04-30 2005-12-15 Morphochem Ag Komb Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
ES2310299T5 (es) 2003-12-18 2014-02-10 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibióticos híbridos a base de oxazolidinona-quinolona
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
EP2316458A1 (en) * 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
RU2405770C2 (ru) 2005-09-27 2010-12-10 Сионоги Энд Ко., Лтд. Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
JP5209254B2 (ja) * 2007-08-30 2013-06-12 日本曹達株式会社 置換フェノキシアザビシクロオクタン誘導体の製造方法
CN108785728A (zh) * 2017-05-05 2018-11-13 国家纳米科学中心 含药物中间体修饰的纳米金的抗菌敷料、其制备方法及应用
CN109503569B (zh) * 2019-01-03 2021-01-15 山东大学 噻唑类衍生物及其制备方法和应用
EP4416140A1 (en) * 2021-10-12 2024-08-21 F. Hoffmann-La Roche AG Sulfonylpiperazinyl compounds for treatment of bacterial infections
AR127435A1 (es) * 2021-10-26 2024-01-24 Hoffmann La Roche Compuestos piperazinilsulfonilarilo para el tratamiento de infecciones bacterianas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
JPS608277A (ja) * 1983-06-07 1985-01-17 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー アミノメチルオキソオキサゾリジニルベンゼン誘導体
ES533097A0 (es) 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
BR9509673A (pt) 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
DK0807112T3 (da) 1995-02-03 2001-12-17 Upjohn Co Antimikrobiel heteroaromatisk ringsubstitueret phenyloxazolidinon
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
US6090820A (en) 1995-05-11 2000-07-18 Pharmacia & Upjohn Company Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
US5883093A (en) 1995-09-12 1999-03-16 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
SG85683A1 (en) 1996-04-11 2002-01-15 Upjohn Co Process to prepare oxazolidinones
FI19992555A7 (fi) 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
AU9001598A (en) 1997-09-11 1999-03-29 Hokuriku Seiyaku Co. Ltd Thiourea derivatives
JPH11322729A (ja) 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体

Also Published As

Publication number Publication date
CN1227238C (zh) 2005-11-16
PT1246810E (pt) 2006-08-31
MY127677A (en) 2006-12-29
US20020103377A1 (en) 2002-08-01
ATE326452T1 (de) 2006-06-15
AU2261701A (en) 2001-07-03
DE60028085D1 (de) 2006-06-22
AU784314B2 (en) 2006-03-09
WO2001046164A1 (en) 2001-06-28
ES2265365T3 (es) 2007-02-16
EP1246810A1 (en) 2002-10-09
DE60028085T2 (de) 2006-12-07
US6518285B2 (en) 2003-02-11
CY1106124T1 (el) 2011-06-08
CA2395204A1 (en) 2001-06-28
JP2003518106A (ja) 2003-06-03
DK1246810T3 (da) 2006-09-18
CO5280081A1 (es) 2003-05-30
CA2395204C (en) 2008-02-05
CN1434810A (zh) 2003-08-06
AR029420A1 (es) 2003-06-25
EP1246810B1 (en) 2006-05-17

Similar Documents

Publication Publication Date Title
ZA200201269B (en) Toothbrush.
ZA200203768B (en) Toothbrush.
ZA200200695B (en) Mutilin derivatives and their use as antibacterials.
GB2349180B (en) Inverted I.C.engine configuration
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
MXPA02001088A (es) 2-pirazolin-5-onas..
MXPA02006325A (es) Maquina precortadora y biseladora.
ZA200202537B (en) Pour-on-formulations.
ZA200201829B (en) New phenylpiperazines.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
GB9910227D0 (en) Fixed wrench
IL165436A0 (en) 7,10-bis-trichlotoacetyl-10 deactylbaccatin III
GB2355714B (en) Ammonium 3,5-diaminopicrate
MXPA02000261A (es) Aminoindanos novedosos.
ZA200108481B (en) 8A- and 9A-15-membered lactams.
GB0029720D0 (en) I.S machine7544232001
GB9913742D0 (en) Horologe improvement
ZA200109039B (en) Brushes.
ZA200204581B (en) Nitro-sulfobenzamides.
GB9928605D0 (en) Rein
IL144237A0 (en) Organoprotective solutions
EG23327A (en) Metraplant "iucd".
ZA200004050B (en) "Articulated structure".
GB9911110D0 (en) Twisted can

Legal Events

Date Code Title Description
FG Grant or registration